These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 17434698)
1. [Cutaneous drug reactions induced by glycopeptides]. Prey S; Sparsa A; Boumediene A; Bonnetblanc JM; Weinbreck P; Denes E Med Mal Infect; 2007 May; 37(5):270-4. PubMed ID: 17434698 [TBL] [Abstract][Full Text] [Related]
2. [Glycopeptide-induced cutaneous adverse reaction]. Nosbaum A; Rozières A; Ben Said B; Nicolas JF; Bérard F Ann Dermatol Venereol; 2010 May; 137(5):341-2. PubMed ID: 20470913 [No Abstract] [Full Text] [Related]
3. [Glycopeptide-induced cutaneous adverse reaction: results of an immunoallergic investigation in eight patients]. Perrin-Lamarre A; Petitpain N; Trechot P; Cuny JF; Schmutz JL; Barbaud A Ann Dermatol Venereol; 2010 Feb; 137(2):101-5. PubMed ID: 20171430 [TBL] [Abstract][Full Text] [Related]
4. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Häusermann P; Harr T; Bircher AJ Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657 [TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006]. Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Gould IM Int J Antimicrob Agents; 2008 Apr; 31 Suppl 2():1-9. PubMed ID: 18485997 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous and systemic adverse reactions to antibiotics. Diaz L; Ciurea AM Dermatol Ther; 2012; 25(1):12-22. PubMed ID: 22591496 [TBL] [Abstract][Full Text] [Related]
8. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens. Das B; Sarkar C; Biswas R; Pandey S Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524 [TBL] [Abstract][Full Text] [Related]
9. Red man syndrome with teicoplanin. Dubettier S; Boibieux A; Lagable M; Crevon L; Peyramond D; Milon H Rev Infect Dis; 1991; 13(4):770. PubMed ID: 1833809 [No Abstract] [Full Text] [Related]
10. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin. Hsiao SH; Chang CM; Tsai JC; Lin CY; Liao LH; Lin WL; Wu TJ Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073 [TBL] [Abstract][Full Text] [Related]
11. Recognition and management of severe cutaneous drug reactions. Knowles SR; Shear NH Dermatol Clin; 2007 Apr; 25(2):245-53, viii. PubMed ID: 17430761 [TBL] [Abstract][Full Text] [Related]
13. Did glycopeptide use in animals result in hospital infections of VRE? Mudd A PLoS Med; 2005 Nov; 2(11):e383. PubMed ID: 16288558 [No Abstract] [Full Text] [Related]